Doripenem in the Treatment of Ventilator-Associated Pneumonia
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the clinical response rate of doripenem versus
comparator in patients with ventilator-associated pneumonia (VAP).
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.